{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T12:19:28Z","timestamp":1765887568749},"reference-count":14,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,10,10]],"date-time":"2013-10-10T00:00:00Z","timestamp":1381363200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.clinthera.2013.09.006","type":"journal-article","created":{"date-parts":[[2013,10,8]],"date-time":"2013-10-08T12:01:59Z","timestamp":1381233719000},"page":"1867-1875","source":"Crossref","is-referenced-by-count":25,"title":["Diagnoses Associated With Use of Atypical Antipsychotics in a Commercial Health Plan: A Claims Database Analysis"],"prefix":"10.1016","volume":"35","author":[{"given":"Leslie","family":"Citrome","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iftekhar","family":"Kalsekar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenchao","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimberly","family":"Laubmeier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tony","family":"Hebden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2013.09.006_bib1","unstructured":"Otsuka Pharmaceutical Co. Abilify maintena (aripiprazole) [prescribing information]. http:\/\/www.otsuka-us.com\/Documents\/Abilify.PI.pdf. Accessed July 2013."},{"key":"10.1016\/j.clinthera.2013.09.006_bib2","unstructured":"Eli Lilly. Zyprexa (olanzapine) [prescribing information]. http:\/\/pi.lilly.com\/us\/zyprexa-pi.pdf. Accessed July 2013."},{"key":"10.1016\/j.clinthera.2013.09.006_bib3","unstructured":"AstraZeneca Pharmaceuticals. Seroquel IR (quetiapine IR) [prescribing information]. http:\/\/www1.astrazeneca-us.com\/pi\/seroquel.pdf. Accessed July 2013."},{"key":"10.1016\/j.clinthera.2013.09.006_bib4","unstructured":"AstraZeneca Pharmaceuticals. Seroquel XR (quetiapine XR) [prescribing information]. http:\/\/www1.astrazeneca-us.com\/pi\/seroquelxr.pdf. Accessed July 2013."},{"key":"10.1016\/j.clinthera.2013.09.006_bib5","unstructured":"Janssen Pharmaceuticals. Risperdal (risperidone) [prescribing information]. http:\/\/www.janssenpharmaceuticalsinc.com\/assets\/risperdal.pdf. Accessed July 2013."},{"key":"10.1016\/j.clinthera.2013.09.006_bib6","unstructured":"Roerig, Division of Pfizer. Geodon (ziprasidone) [prescribing information]. http:\/\/labeling.pfizer.com\/ShowLabeling.aspx?id=584. Accessed July 2013."},{"key":"10.1016\/j.clinthera.2013.09.006_bib7","first-page":"e109","article-title":"Off-label use of antipsychotic medications in medicaid","volume":"18","author":"Leslie","year":"2012","journal-title":"Am J Manag Care"},{"key":"10.1016\/j.clinthera.2013.09.006_bib8","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1176\/ps.2009.60.9.1175","article-title":"Off-label use of antipsychotic medications in the department of Veterans Affairs health care system","volume":"60","author":"Leslie","year":"2009","journal-title":"Psychiatr Serv"},{"key":"10.1016\/j.clinthera.2013.09.006_bib9","unstructured":"Maglione M, Maher AR, Hu J, et al. Off-label use of atypical antipsychotics: an update. http:\/\/effectivehealthcare.ahrq.gov\/ehc\/products\/150\/778\/CER43_Off-LabelAntipsychotics_20110928.pdf. Accessed July 2013."},{"key":"10.1016\/j.clinthera.2013.09.006_bib10","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.4088\/JCP.v69n1003","article-title":"Patterns of atypical antipsychotic subtherapeutic dosing among Oregon Medicaid patients","volume":"69","author":"Hartung","year":"2008","journal-title":"J Clin Psych"},{"key":"10.1016\/j.clinthera.2013.09.006_bib11","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1055\/s-2003-43048","article-title":"Off-label use of antipsychotics in the community pharmacy: the sex differences","volume":"36","author":"Rijcken","year":"2003","journal-title":"Pharmacopsychiatry"},{"key":"10.1016\/j.clinthera.2013.09.006_bib12","unstructured":"AstraZeneca Pharmaceuticals. Seroquel XR (quetiapine fumarate) extended-release tablets for the treatment of patients with either major depressive disorder or generalized anxiety disorder. http:\/\/www.fda.gov\/downloads\/AdvisoryCommittees\/CommitteesMeetingMaterials\/Drugs\/PsychopharmacologicDrugsAdvisoryCommittee\/UCM161963.pdf. Accessed September 26, 2012."},{"key":"10.1016\/j.clinthera.2013.09.006_bib13","first-page":"16","article-title":"Outpatient use of major antipsychotic drugs in ambulatory care settings in the United States, 1997\u20132000","volume":"5","author":"Van Brunt","year":"2003","journal-title":"MedGenMed"},{"key":"10.1016\/j.clinthera.2013.09.006_bib14","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1046\/j.1532-5415.2003.51506.x","article-title":"Treatment of elderly and other adult patients for depression in primary care","volume":"51","author":"Fischer","year":"2003","journal-title":"J Am Geriatr Soc"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291813009533?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291813009533?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,12]],"date-time":"2018-10-12T09:53:58Z","timestamp":1539338038000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291813009533"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":14,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S0149291813009533"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2013.09.006","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]}}}